Elekta and Stockholm County Council agree on constructive way forward

Elekta will continue to fully equip the new radiation therapy department of Stockholm South General Hospital (SöS) and to provide brachytherapy solutions to New Karolinska Solna (NKS). Stockholm County Council will have the possibility to seek a separate solution for the remaining external beam equipment at NKS.

Richard Hausmann, Elekta President and CEO, commented: “The Letter of Intent provides both parties with a constructive way to move forward and collaborate for Stockholm County Council to expand cancer care services. As a Stockholm-based company we look forward to continue providing advanced, world-class cancer care to the patients of Stockholm.”

The Letter of Intent is expected to be turned into a binding contract latest January 31, 2018.

The value of the remaining part of the contract is expected to be approximately SEK 160 million; the initial order value was approximately SEK 350 million over the 13-year lifetime of the agreement.

# # #

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: [email protected]
Time zone: CET: Central European Time

Tobias Bülow, Director Financial Communications, Elekta AB
Tel: +46 722 215 017, e-mail: [email protected]
Time zone: CET: Central European Time

This is information that Elekta AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 13:00 CET on December 12, 2017. (REGMAR)

About Elekta
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com